Device brand name · Staple implantable
Echelon Endopath: medical device reports filed with FDA
565 reports name it, 2014–2026. Manufacturer given most often on reports: Ethicon Endo-Surgery. Product code GDW.
- 565
- device reports naming the brand
- 0% of all MAUDE reports · about 46 a year
- 460
- reports, 12 months to August 2026
- 3 in the 12 months before
- 92.7%
- classified as malfunction
- 80.3% across the product code
- 0.2%
- classified as death, as reported
- 1 reports · not verified by FDA
FDA's MAUDE database holds 565 reports that name the brand "Echelon Endopath" (staple implantable), received between February 2014 and August 2026; the manufacturer given most often on reports is Ethicon Endo-Surgery. Spellings of one product vary from report to report.
460 reports arrived in the 12 months to August 2026, up 15233% from 3 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.7%), injury (7.1%) and death (0.2%); across all staple, implantable reports (product code GDW) death is recorded in 0.6% and malfunction in 80.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to form staple (40.4%), failure to fire (20%) and difficult to open or close (7.3%). The patient problems coded most often are hemorrhage/blood loss/bleeding, failure to anastomose and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 170,752 reports carrying product code GDW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to form staple | 228 | 40.4% | 20.5% |
| Failure to fire | 113 | 20% | 30% |
| Difficult to open or close | 41 | 7.3% | 9.7% |
| Material integrity problema problem with the device material | 28 | 5% | 0.7% |
| Separation problem | 25 | 4.4% | 0.2% |
| Ejection problem | 13 | 2.3% | 0.8% |
| Patient device interaction problem | 12 | 2.1% | 0.7% |
| Delivered as unsterile product | 10 | 1.8% | 0.3% |
| Mechanical jam | 10 | 1.8% | 2.3% |
| Insufficient device problem information | 5 | 0.9% | 2.9% |
| Mechanical problema mechanical problem | 5 | 0.9% | 1.1% |
| Unintended ejection | 5 | 0.9% | 0.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 4 | 0.7% | 2.3% |
| Failure to cut | 4 | 0.7% | 2.4% |
| Component falling | 3 | 0.5% | 0.5% |
| Structural problem | 3 | 0.5% | 0.1% |
| Detachment of device component | 2 | 0.4% | 1.2% |
| Device misassembled during manufacturing /shipping | 2 | 0.4% | 0.1% |
| Difficult to removethe device was hard to remove | 2 | 0.4% | 1.7% |
| Leak/splashthe device leaked | 2 | 0.4% | 0.5% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemorrhage/blood loss/bleeding | 43 | 7.6% |
| Failure to anastomose | 9 | 1.6% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 7 | 1.2% |
| Blood loss | 7 | 1.2% |
| Ecchymosis | 7 | 1.2% |
| Foreign body in patientpart of a device left in the patient | 6 | 1.1% |
| Not applicable | 5 | 0.9% |
| Fistula | 4 | 0.7% |
| Fever | 2 | 0.4% |
| Hematomaa collection of blood under the skin or in tissue | 2 | 0.4% |
| No patient involvement | 2 | 0.4% |
| Abscessa collection of pus | 1 | 0.2% |
| Deaththe patient died; cause not stated by this term | 1 | 0.2% |
| Dysphagia/ odynophagia | 1 | 0.2% |
| Heartburn/indigestion | 1 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Echelon Endopath | Product code GDW | All MAUDE reports |
|---|---|---|---|
| Reports | 565 | 170,752 | 26,136,888 |
| Share of that pool | — | 0.3% | 0% |
| Classified as death, per 1,000 reports | 2 | 6 | 9 |
| Classified as injury | 7.1% | 18.7% | 36.2% |
| Classified as malfunction | 92.7% | 80.3% | 62.3% |
| Filed by the manufacturer | 91.7% | 97% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code GDW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Endo GIA | 30,619 | 2,086 | 0.3% |
| Endo GIA Ultra | 17,281 | 1,116 | 0.1% |
| Signia | 9,434 | 1,130 | 0.1% |
| Tri-Staple 2.0 | 5,267 | 661 | 0.3% |
| Gia | 4,899 | 404 | 0.9% |
| Eea | 4,922 | 542 | 0.8% |
| Powered 60 Echelon + 340mm Shaft | 3,237 | 224 | 0.4% |
| Ets Flex Articng Lnr Cutr 45mm | 2,512 | 79 | 0.3% |
| Unknown Endo GIA SULU | 2,408 | 205 | 1.9% |
| SureForm | 2,927 | 654 | 1.2% |
| Contour Curved Cutter Stapler | 1,961 | 11 | 0.3% |
| Ils 29mm Curved | 1,945 | 48 | 0.9% |
| Powered 60 Echelon + 440mm Shaft | 1,775 | 49 | 0.4% |
| Echelon Flex Powered Vascular Stapler With Advanced Placement Tip | 1,770 | 180 | 1.6% |
| 75mm Selectable New Tlc | 1,603 | 57 | 1.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Echelon Endopath reports
How many FDA reports name Echelon Endopath?
565 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 460 in the latest 12 months.
What kinds of events are reported?
malfunction (92.7%), injury (7.1%) and death (0.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to form staple (40.4%), failure to fire (20%), difficult to open or close (7.3%), material integrity problem (5%) and separation problem (4.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (91.7%) and voluntary reports (0.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Echelon Endopath was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.